Title: Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.
Authors: Jotanovic, Jelena; Boldt, Henning Bünsow; Burton, Mark; Andersen, Marianne Skovsager; Bengtsson, Daniel; Bontell, Thomas Olsson; Ekman, Bertil; Engström, Britt Edén; Feldt-Rasmussen, Ulla; Heck, Ansgar; Jakovcevic, Antonia; Jørgensen, Jens Otto L.; Kraljevic, Ivana; Kunicki, Jacek; Lindsay, John R.; Losa, Marco; Loughrey, Paul Benjamin; Maiter, Dominique; Maksymowicz, Maria; Manojlovic-Gacic, Emilija
Abstract: The correction notice in Acta Neuropathologica addresses formatting errors in Table 2 of the original article "Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors." The incorrect and correct versions of Table 2 are provided in the correction, highlighting significantly enriched gene sets associated with different tumor types. The correction ensures accuracy in the presentation of data for research on pituitary neuroendocrine tumors.
Subjects: CELL adhesion molecules; HEDGEHOG signaling proteins; NEUROENDOCRINE tumors; PITUITARY tumors; CHAR; EPHRIN receptors; CELL adhesion
Publication: Acta Neuropathologica, 2025, Vol 149, Issue 1, p1
ISSN: 0001-6322
Publication type: Academic Journal
DOI: 10.1007/s00401-024-02838-3

Correction: Genome‑wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.

CELL adhesion molecules; HEDGEHOG signaling proteins; NEUROENDOCRINE tumors; PITUITARY tumors; CHAR; EPHRIN receptors; CELL adhesion